Research identifies new target for antiplatelet therapy.

Cleveland Clinic researchers have identified a specific olfactory receptor on platelets as a novel therapeutic target for thrombosis. This approach suppressed dangerous clot formation without increasing bleeding risk, potentially offering a significant advantage over current antiplatelet drugs. The findings, published in Circulation, could lead to safer treatments for blood clots.